Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,152 INR | -0.41% | +1.80% | +6.24% |
02/05 | Aurobindo Pharma Completes Sale of US Arm's Business Assets | MT |
07/04 | Aurobindo Pharma Limited Announces Appointment of T. Vijaya Kumar as President R&D (Specialty Drug Delivery) | CI |
ETFs positioned on Aurobindo Pharma
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.32% | 6 M€ | +6.07% | - | |
0.22% | 18 M€ | +6.49% | ||
0.12% | 11 M€ | +4.66% | ||
0.09% | 3 M€ | -.--% | - | |
0.09% | 1 M€ | +3.49% | - | |
0.05% | 2,808 M€ | +8.23% | - | |
0.05% | 441 M€ | +7.05% | - | |
0.05% | 149 M€ | +5.36% | - | |
0.03% | 4 M€ | -4.41% | - | |
0.02% | 117 M€ | +2.11% | - | |
0.01% | 7 M€ | +23.15% | - | |
0.01% | 31 M€ | +5.22% | - | |
0.01% | 7 M€ | +3.48% | - | |
0.00% | 34 M€ | +2.67% | - | |
0.00% | 15 M€ | +12.19% | ||
0.00% | 16 M€ | -4.51% | ||
0.00% | 34 M€ | +6.71% | - | |
0.00% | 389 M€ | +7.11% | - | |
0.00% | 39 M€ | +4.35% | - | |
0.00% | 302 M€ | +4.66% | - | |
0.00% | 17 M€ | +1.96% | - | |
0.00% | 108 M€ | +2.36% | - | |
0.00% | 52 M€ | -0.11% | - | |
0.00% | 8 M€ | -0.02% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.24% | 8.09B | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- AUROPHARMA Stock
- Funds and ETFs Aurobindo Pharma